Profile
Mark K.
Bennett worked as a Director-Cell Biology at Rigel Pharmaceuticals, Inc. from 1999 to 2003.
Prior to that, he was a Professor at the University of California, Berkeley from 1993 to 1999.
From 2003 to 2009, he worked as a Vice President-Research at Proteolix, Inc. He also held the position of Senior Vice President-Research at Calithera Biosciences, Inc. Dr. Bennett holds a doctorate degree from the California Institute of Technology and an undergraduate degree from Oregon State University.
Former positions of Mark K. Bennett
Companies | Position | End |
---|---|---|
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Chief Tech/Sci/R&D Officer | 2009-01-01 |
RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2002-12-31 |
University of California, Berkeley | Corporate Officer/Principal | 1998-12-31 |
CALITHERA BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Training of Mark K. Bennett
Oregon State University | Undergraduate Degree |
California Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
RIGEL PHARMACEUTICALS, INC. | Health Technology |
CALITHERA BIOSCIENCES, INC. | Health Technology |
Private companies | 1 |
---|---|
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
- Stock Market
- Insiders
- Mark K. Bennett